Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
1.
Am J Med ; 134(6): 721-726, 2021 06.
Article in English | MEDLINE | ID: mdl-33610522

ABSTRACT

Approximately 1%-2% of hospitalizations in the United States result in an against medical advice discharge. Still, the practice of discharging patients against medical advice is highly subjective and variable. Discharges against medical advice are associated with physician distress, patient stigma, and adverse outcomes, including increased morbidity and mortality. This review summarizes discharge against medical advice research, proposes a definition for against medical advice discharge, and recommends a standard approach to a patient's request for discharge against medical advice.


Subject(s)
Patient Discharge/standards , Treatment Refusal/psychology , Hospitalization/trends , Humans , Patient Discharge/trends , Risk Factors , Treatment Refusal/trends , United States
2.
Nurs Inq ; 28(1): e12380, 2021 01.
Article in English | MEDLINE | ID: mdl-32955787

ABSTRACT

As a result of the coronavirus (COVID-19) pandemic, health professionals are faced with situations they have not previously encountered and are being forced to make difficult ethical decisions. As the first group to experience challenges of caring for patients with coronavirus, Chinese nurses endure heartbreak and face stressful moral dilemmas. In this opinion piece, we examine three related critical questions: Whether society has the right to require health professionals to risk their lives caring for patients; whether health professionals have the right to refuse to care for patients during the coronavirus pandemic; and what obligations there are to protect health professionals? Value of care, community expectations, legal obligations, professional and codes of practice may compel health professionals to put themselves at risks in emergency situations. The bioethical principles of autonomy, justice, beneficence and non-maleficence, as well as public health ethics, guide nurses to justify their decisions as to whether they are entitled to refuse to treat COVID-19 patients during the pandemic. We hope that the open discussion would support the international society in addressing similar ethical challenges in their respective situations during this public health crisis.


Subject(s)
COVID-19/prevention & control , Treatment Refusal/ethics , COVID-19/transmission , China , Humans , Pandemics/prevention & control , Pandemics/statistics & numerical data , Public Health/instrumentation , Public Health/methods , Treatment Refusal/trends
3.
Dig Dis Sci ; 66(2): 424-433, 2021 02.
Article in English | MEDLINE | ID: mdl-32361924

ABSTRACT

BACKGROUND AND AIMS: Leaving against medical advice (LAMA) is an unfortunate occurrence in 1-2% of all hospitalized patients and is associated with worse outcomes. While this has been investigated across multiple clinical conditions, studies on patients with chronic pancreatitis (CP) are lacking. We aimed to determine the prevalence and determinants of this event among patients with CP. METHODS: The Healthcare Cost and Utilization Project-Nationwide Inpatient Sample (NIS), 2007-2014, was used in the study. Patients with LAMA were identified, and the temporal trend of LAMA was estimated and compared among patients with and without CP. We then extracted patients with a discharge diagnosis of CP from the recent years of HCUP-NIS (2012-2014) and described the characteristics of LAMA in these patients. Multivariate logistic regression models were used to evaluate predictors of LAMA. RESULTS: 3.39% of patients with CP discharged against medical advice. LAMA rate in CP patients was higher and increased more steeply at quadruple the rate of those without. More likely to self-discharge were patients who were young, males, non-privately insured, or engaged in alcohol and substance abuse, likewise were those with psychosis and those admitted on a weekend or non-electively. The northeast and for-profit hospitals also had higher odds of LAMA. However, patients transferred from other healthcare facilities have reduced LAMA odds. Among all patients with CP, those with LAMA had shorter length of stay (2.74 [2.62-2.85] days vs. 5.78 [5.71-5.83] days) and lower hospitalization cost $23,271 [$22,171-$24,370] versus $45,472 [$44,381-$46,562] compared to the no-LAMA group. CONCLUSION: LAMA occurs in approximately 1 in 29 patients with CP and is increasing at almost quadruple the rate of those without. Clinicians need to pay closer attention to the identified at-risk groups for ameliorative targeted interventions.


Subject(s)
Pancreatitis, Chronic/epidemiology , Pancreatitis, Chronic/therapy , Patient Acceptance of Health Care , Patient Discharge/trends , Treatment Refusal/trends , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Pancreatitis, Chronic/psychology , Predictive Value of Tests , Prevalence , Retrospective Studies , Treatment Refusal/psychology , Young Adult
6.
Nord J Psychiatry ; 74(5): 323-326, 2020.
Article in English | MEDLINE | ID: mdl-31906772

ABSTRACT

Objective: Current Danish legislation imposes that compulsory admitted psychotic patients have the right to refuse antipsychotic medication, which markedly delays pertinent medical treatment.Material and methods: In a retrospective, observational cohort study, we analyzed data from a 1-year period on 34 consecutively admitted patients with schizophrenia, who had been compulsory admitted due to need of treatment, or because they were judged to constitute an acute danger to themselves or others. We compared the use of other coercive procedures and hospitalization time.Results: Twenty-three patients accepted to commence antipsychotic treatment immediately, and 11 patients submitted an official complaint, which significantly delayed initiation of antipsychotic treatment (1 day ±0.9 versus 14 days ±10.1, p = 0.002). The 11 complaining patients were subjected to 6.8 times more coercive procedures of forced sedative medication compared to the 23 patients without delay (2.7 ± 2.3 episodes versus 0.4 ± 0.7 episodes, p = 0.007). Moreover, the treatment-delay prolonged duration of hospitalization by a factor 2.3 (73.3 ± 28.3 days versus 31.7 ± 22.0 days, p < 0.001).Conclusion: The current legislation intends to preserve patient rights and promote voluntary treatment alliance but may instead lead to prolonged hospitalization and increased use of other coercive measures such as forced sedative medication. Modification of current legislation may therefore be considered.


Subject(s)
Antipsychotic Agents/therapeutic use , Coercion , Hospitals, Psychiatric/trends , Patient Admission/trends , Psychotic Disorders/drug therapy , Treatment Refusal/trends , Adult , Aged , Cohort Studies , Denmark/epidemiology , Female , Hospitalization/trends , Humans , Male , Middle Aged , Psychotic Disorders/epidemiology , Psychotic Disorders/psychology , Retrospective Studies , Schizophrenia/drug therapy , Schizophrenia/epidemiology , Treatment Refusal/psychology , Young Adult
7.
Eur J Health Law ; 27(2): 125-145, 2020 05 14.
Article in English | MEDLINE | ID: mdl-33652401

ABSTRACT

'Do not resuscitate' (DNR) imprints on the human body have recently appeared in medical practice. These non-standard DNR orders (e.g., tattoos, stamps, patches) convey the patient's refusal of resuscitation efforts should he be incapable of doing so. The article focuses on such innovative tools to express one's end-of-life wishes. Switzerland provides a unique example, as 'No Cardio-Pulmonary Resuscitation' stamps and patches have been commercialised. The article discusses the challenging legal questions as to the validity of non-standard DNR orders imprinted on the human body. It analyses the obligation of healthcare providers to honour such orders, either as an advance directive or an expression of an individual's presumed wishes, and withhold treatment. Finally, the article addresses the balancing of interests between the presumed wishes of an unconscious patient and his best interests of being resuscitated and potentially staying alive, a dilemma facing healthcare providers in a medical emergency.


Subject(s)
Advance Directives/legislation & jurisprudence , Human Body , Treatment Refusal/trends , Advance Directive Adherence/standards , Emergency Medical Services/legislation & jurisprudence , Emergency Responders/legislation & jurisprudence , Humans , Switzerland , Withholding Treatment/standards
8.
Subst Abus ; 41(3): 400-407, 2020.
Article in English | MEDLINE | ID: mdl-31361589

ABSTRACT

Background: With the rapid rise in opioid overdose-related deaths, state policy makers have expanded policies to increase the use of naloxone by emergency medical services (EMS). However, little is known about changes in EMS naloxone administration in the context of continued worsening of the opioid crisis and efforts to increase use of naloxone. This study examines trends in patient demographics and EMS response characteristics over time and by county urbanicity. Methods: We used data from the 2013-2016 National EMS Information System to examine trends in patient demographics and EMS response characteristics for 911-initiated incidents that resulted in EMS naloxone administration. We also assessed temporal, regional, and urban-rural variation in per capita rates of EMS naloxone administrations compared with per capita rates of opioid-related overdose deaths. Results: From 2013 to 2016, naloxone administrations increasingly involved young adults and occurred in public settings. Particularly in urban counties, there were modest but significant increases in the percentage of individuals who refused subsequent treatment, were treated and released, and received multiple administrations of naloxone before and after arrival of EMS personnel. Over the 4-year period, EMS naloxone administrations per capita increased at a faster rate than opioid-related overdose deaths across urban, suburban, and rural counties. Although national rates of naloxone administration were consistently higher in suburban counties, these trends varied across U.S. Census Regions, with the highest rates of suburban administration occurring in the South. Conclusions: Naloxone administration rates increased more quickly than opioid deaths across all levels of county urbanicity, but increases in the percentage of individuals requiring multiple doses and refusing subsequent care require further attention.


Subject(s)
Emergency Medical Services/trends , Naloxone/therapeutic use , Narcotic Antagonists/therapeutic use , Opiate Overdose/drug therapy , Adult , Female , Humans , Male , Middle Aged , Patient Transfer/trends , Rural Population/trends , Suburban Population/trends , Transportation of Patients/trends , Treatment Refusal/trends , Urban Population/trends , Young Adult
10.
Int J Health Policy Manag ; 8(8): 474-479, 2019 08 01.
Article in English | MEDLINE | ID: mdl-31441287

ABSTRACT

BACKGROUND: Approximately 1% to 2% of hospitalized patients get discharged or leave from the hospital against medical advice and up to 26% in some centers. They have higher readmission rate and risk of complications than patients who receive complete care. In this study we aimed to determine the rate of leave against medical advice (LAMA) and reasons for the same across different in-patient departments of a tertiary care hospital. METHODS: Retrospective cohort study on patients admitted in all departments at our institute over a 1-year period. All patients who were admitted to an in-patient ward at the hospital and who left against medical advice by submitting a duly filled LAMA form were included. Univariate and multivariate logistic regression models with forward selection methods were employed. Revisit to hospital within 30 days; to clinic or emergency department was outcome variable for regression. RESULTS: From June 2015 to May 2016 there were 429 LAMA patients, accounting for 0.7% of total admissions. Females were 223 (52%) compared to males 206 (48%). Finances were quoted as the most common reason for LAMA by 174 (41%) patients followed by domestic problems 78 (18%). Internal medicine was the service with the highest number of LAMA patients ie, 153 (36%) followed by Pediatric medicine with 73 (17%). Of the 429 patients, 147 (34%) patients revisited the hospital within 30 days. Sixty-one percent of these 'bounced-back' LAMA patients had worsening or persistence of same problem, or new problem/s had developed. In unadjusted bivariate logistic model, patients who were advised for follow-up during discharge against medical advice were four times more likely to revisit the hospital. Patients who were married had an increased odd of revisiting the hospital. CONCLUSION: Financial reasons are the most common stated reasons to LAMA. Patients who LAMA are at a high risk of clinical worsening and 'bouncing back.' This is the first study from our region on in-patient LAMA rates, to our knowledge. The results can be used for planning measures to reduce LAMA rates and its consequences.


Subject(s)
Patient Acceptance of Health Care/statistics & numerical data , Patient Compliance/statistics & numerical data , Patient Discharge/trends , Patient Readmission/trends , Treatment Refusal/trends , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Cohort Studies , Female , Humans , Infant , Male , Middle Aged , Outcome Assessment, Health Care , Patient Acceptance of Health Care/psychology , Patient Compliance/psychology , Retrospective Studies , Socioeconomic Factors , Tertiary Care Centers , Treatment Refusal/psychology , Young Adult
11.
Circ Cardiovasc Qual Outcomes ; 12(8): e005562, 2019 08.
Article in English | MEDLINE | ID: mdl-31416347

ABSTRACT

BACKGROUND: Female patients have historically received less aggressive lipid management than male patients. Contemporary care patterns and the potential causes for these differences are unknown. METHODS AND RESULTS: Examining the Patient and Provider Assessment of Lipid Management Registry-a nationwide registry of outpatients with or at risk for atherosclerotic cardiovascular disease-we compared the use of statin therapy, guideline-recommended statin dosing, and reasons for undertreatment. We specifically analyzed sex differences in statin treatment and guideline-recommended statin dosing using multivariable logistic regression. Among 5693 participants (43% women) eligible for 2013 American College of Cardiology/American Heart Association Cholesterol Guideline-recommended statin treatment, women were less likely than men to be prescribed any statin therapy (67.0% versus 78.4%; P<0.001) or to receive a statin at the guideline-recommended intensity (36.7% versus 45.2%; P<0.001). Women were more likely to report having previously never been offered statin therapy (18.6% versus 13.5%; P<0.001), declined statin therapy (3.6% versus 2.0%; P<0.001), or discontinued their statin (10.9% versus 6.1%; P<0.001). Women were also less likely than men to believe statins were safe (47.9% versus 55.2%; P<0.001) or effective (68.0% versus 73.2%; P<0.001) and more likely to report discontinuing their statin because of a side effect (7.9% versus 3.6%; P<0.001). Sex differences in both overall and guideline-recommended intensity statin use persisted after adjustment for demographics, socioeconomic factors, clinical characteristics, patient beliefs, and provider characteristics (adjusted odds ratio, 0.70; 95% CI, 0.61-0.81; P<0.001; and odds ratio, 0.82; 95% CI, 0.73-0.92; P<0.01, respectively). Sex differences were consistent across primary and secondary prevention indications for statin treatment. CONCLUSIONS: Women eligible for statin therapy were less likely than men to be treated with any statin or guideline-recommended statin intensity. A combination of women being offered statin therapy less frequently, while declining and discontinuing treatment more frequently, accounted for these sex differences in statin use.


Subject(s)
Cardiovascular Diseases/prevention & control , Community Health Services/trends , Dyslipidemias/drug therapy , Healthcare Disparities/trends , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Medication Adherence , Practice Patterns, Physicians'/trends , Treatment Refusal/trends , Aged , Cardiovascular Diseases/diagnosis , Cardiovascular Diseases/epidemiology , Dyslipidemias/diagnosis , Dyslipidemias/epidemiology , Female , Guideline Adherence/trends , Health Knowledge, Attitudes, Practice , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects , Male , Middle Aged , Practice Guidelines as Topic , Primary Prevention/trends , Registries , Risk Assessment , Risk Factors , Secondary Prevention/trends , Sex Factors , Time Factors , Treatment Outcome , United States/epidemiology
12.
Emerg Med Australas ; 31(3): 321-331, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30943579

ABSTRACT

The aim of this systematic review and meta-analysis was to evaluate the outcomes of patients who are not transported to hospital following ambulance attendance. A database search was conducted using PubMed, Medline, Embase, CINAHL and Cochrane Library. Studies were included if they analysed the outcomes of patients who were not transported following ambulance attendance. The primary outcome of this review was subsequent presentation to an ED following a non-transport decision. Secondary outcome measures included hospital admission, subsequent presentation to alternative service provider (e.g. private physician), and death at follow up. The search yielded 1953 non-duplicate articles, of which 10 met the inclusion criteria. Three studies specified that the non-transport decision was emergency medical services (EMS)-initiated, seven studies did not specify. Meta-analysis found substantial heterogeneity between estimates (I2 >50%) that was likely because of differences in study design, length of follow up, patient demographic and sample size. Between 5% and 46% (pooled estimate 21%; 95% CI 11-31%) of non-transport patients subsequently presented to ED. Few (pooled estimate 8%; 95% CI 5-12%) EMS-initiated non-transport patients were admitted to hospital compared to the unspecified group (pooled estimate 40%; 95% CI 7-72%). Mortality rates were low across included studies. Studies found varying estimates for the proportion of patients discharged at the scene that subsequently presented to ED. Few patients were admitted to hospital when the non-transport decision was initiated by EMS, indicating EMS triage is a relatively safe practice. More research is needed to elucidate the context of non-transport decisions and improve access to alternative pathways.


Subject(s)
Emergency Medical Services/standards , Outcome Assessment, Health Care/standards , Treatment Refusal/trends , Ambulances , Emergency Medical Services/trends , Humans , Outcome Assessment, Health Care/trends , Treatment Refusal/psychology , Triage
13.
Med Leg J ; 87(1): 23-26, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30706758

ABSTRACT

This article considers situations where treatment is refused and whether this is reasonable taking into account statutory duties, efficacy of treatment, the role and advice of NICE, local and general resources. What should be the priorities for treatment? Eligibility for treatment, the economic case for an early intervention and/or preventative medicine, caesarean sections, human rights, examples from the cases.


Subject(s)
State Medicine/economics , Treatment Refusal/legislation & jurisprudence , Health Care Costs/standards , Human Rights , Humans , Jurisprudence , Patient Rights , State Medicine/organization & administration , Treatment Refusal/ethics , Treatment Refusal/trends , United Kingdom
16.
Pediatrics ; 142(2)2018 08.
Article in English | MEDLINE | ID: mdl-30030367

ABSTRACT

BACKGROUND AND OBJECTIVE: Refusal of intramuscular (IM) vitamin K administration by parents is an emerging problem. Our objective was to assess the frequency of and factors associated with refusal of IM vitamin K administration in well newborns in the United States. METHODS: We determined the number of newborns admitted to well newborn units whose parents refused IM vitamin K administration in the Better Outcomes through Research for Newborns network and, in a nested patient-control study, identified factors associated with refusal of IM vitamin K administration by using a multiple logistic regression model. RESULTS: Of 102 878 newborns from 35 Better Outcomes through Research for Newborns sites, parents of 638 (0.6%) refused IM vitamin K administration. Frequency of refusal at individual sites varied from 0% to 2.3%. Exclusive breastfeeding (adjusted odds ratio [aOR] = 3.4; 95% confidence interval [CI]: 2.1-5.5), non-Hispanic white race and/or ethnicity (aOR = 1.7; 95% CI: 1.2-2.4), female sex (aOR = 1.6; 95% CI: 1.2-2.3), gestational age (aOR = 1.2; 95% CI: 1.1-1.4), and mother's age (aOR = 1.05; 95% CI: 1.02-1.08) were significantly associated with refusal of IM vitamin K administration. Refusal of the administration of both ocular prophylaxis and hepatitis B vaccine was also strongly associated with refusal of IM vitamin K administration (aOR = 88.7; 95% CI: 50.4-151.9). CONCLUSIONS: Refusal of IM vitamin K by parents of newborns is a significant problem. Interventions to minimize risks to these newborns are needed.


Subject(s)
Parents/psychology , Treatment Refusal/psychology , Treatment Refusal/trends , Vitamin K Deficiency Bleeding/prevention & control , Vitamin K/administration & dosage , Adolescent , Adult , Female , Humans , Infant, Newborn , Injections, Intramuscular , Male , Middle Aged , United States/epidemiology , Vitamin K Deficiency Bleeding/epidemiology , Vitamin K Deficiency Bleeding/psychology , Young Adult
18.
Rev. esp. drogodepend ; 43(1): 29-47, ene.-mar. 2018. tab, graf
Article in Spanish | IBECS | ID: ibc-171742

ABSTRACT

Introducción: La baja adherencia al tratamiento constituye en adictos un factor facilitador de una posible recaída, siendo otro predictor del fracaso terapéutico la dependencia emocional. Objetivos: Explorar el constructo Bidependencia, entendido como una doble dependencia (a sustancias psicoactivas y a relaciones interpersonales), determinando un perfil diferencial respecto a una adicción únicamente a sustancias y relacionarlo con la percepción del riesgo de abandono y la adherencia al tratamiento. Metodología: La muestra consta de 107 participantes adictos en tratamiento y cuyas edades fluctúan entre los 18 y los 66 años (Media: 45,54; DT: 10,15). Resultados: Se ha hallado un perfil clínico diferencial entre adictos bidependientes y sujetos adictos no bidependientes. También se presentan diferencias significativas entre estos dos grupos en la percepción del riesgo de abandono y la adherencia al tratamiento, siendo el grupo bidependiente el que presenta mayor riesgo de fracaso terapéutico. Conclusiones: Dada la importancia de la adherencia al tratamiento en adictos se invita a una reflexión y se aboga por dar continuidad a esta novedosa línea de investigación


The aim of this piece of research is to explore the bidependency construct, which can be understood as double dependency (on a psychoactive substance and interpersonal relationships), shaping a different profile with respect to an addiction only to substances. The sample was made up of 115 participants in treatment of both sexes and of ages from 18 to 66, at the time of the investigation, (Querage: 45.54; SD: 10.15). The research used the Spouce- Specific Dependency - SSDS- (Rathus & O'Leary, 1997, adapted by Esposito et al., 2000), the Inventory of Interpersonal Relationships and Sentimental Dependencies -IRIDS 100- (Sirvent & Moral, 2007, and the Questionnaire Prediction of Therapeutic Abandonment in addiction (vs. Success) -VPA 30- (Sirvent, 2009). A different clinical profile was discovered between bidependent addicts and non-bidependent addicts. Significant differences were also found between these two groups with regard to adherence to the treatment and the risk of abandonment. The bidependent group were the ones with the greatest risk. This calls for reflection and continuing with a new line of research


Subject(s)
Humans , Male , Female , Young Adult , Adult , Middle Aged , Substance-Related Disorders/prevention & control , Substance-Related Disorders/therapy , Medication Adherence/psychology , Treatment Failure , Dependency, Psychological , Risk Factors , Treatment Refusal/trends , Surveys and Questionnaires , Brief Psychiatric Rating Scale , Data Analysis/methods
19.
Clin Breast Cancer ; 18(4): e469-e476, 2018 08.
Article in English | MEDLINE | ID: mdl-28784267

ABSTRACT

BACKGROUND: It has been reported that some patients with breast cancer may refuse cancer-directed surgery, but the incidence in the United States is not currently known. The purpose of this study was to identify the incidence, trends, risk factors, and eventual survival outcomes associated with refusal of recommended breast cancer-directed surgery. PATIENTS: A retrospective review of the Surveillance Epidemiology and End Results (SEER) database between 2004 and 2013 was performed. Patients who underwent cancer-directed surgery were compared with patients in whom cancer-directed surgery was refused, even though it was recommended. RESULTS: Of 531,700 patients identified, 3389 (0.64%) refused surgery. An increasing trend was observed from 2004 to 2013 (P = .009). Older age (50-69: odds ratio [OR] 4.96; 95% confidence interval, 1.23-19.96; P = .024, ≥ 70 years: OR 17.27; 95% CI, 4.29-69.54; P < .001), ethnicity (P < .001), marital status (single: OR 2.28; 95% CI, 1.98-2.62; P < .001, separated/divorced/widowed: OR 2.26; 95% CI, 2.01-2.53; P < .001), higher stage (II: OR 2.05; 95% CI, 1.83-2.3; P < .001, III: OR 2.2; 95% CI, 1.87-2.6; P < .001, IV: OR 13.3; 95% CI, 11.67-15.16; P < .001), and lack of medical insurance (OR 2.11; 95% CI, 1.59-2.8; P < .001) were identified as risk factors associated with refusal of surgery. Survival analysis showed a 2.42 higher risk of mortality in these patients. CONCLUSION: There has been an increasing rate of patients refusing recommended surgery, which significantly affects survival. Age, ethnicity, marital status, disease stage, and lack of insurance are associated with higher risk of refusal of surgery.


Subject(s)
Breast Neoplasms/surgery , Treatment Refusal/statistics & numerical data , Adult , Aged , Breast Neoplasms/epidemiology , Breast Neoplasms/mortality , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , SEER Program/statistics & numerical data , Survival Analysis , Treatment Refusal/trends , United States , Young Adult
20.
Mayo Clin Proc ; 92(4): 525-535, 2017 04.
Article in English | MEDLINE | ID: mdl-28291588

ABSTRACT

OBJECTIVE: To describe the national frequency, prevalence, and trends of discharge against medical advice (DAMA) among inpatient hospitalizations in the United States and identify differences across patient- and hospital-level characteristics, overall and in clinically distinct diagnostic subgroups. PATIENTS AND METHODS: We conducted a retrospective, cross-sectional analysis of inpatient hospitalizations (≥18 years), discharged between January 1, 2002, and December 31, 2011, using the Nationwide Inpatient Sample. Descriptive statistics, multivariable logistic, and joinpoint regression were used for statistical analyses. RESULTS: Between January 1, 2002, and December 31, 2011, more than 338,000 inpatient hospitalizations were discharged against medical advice each year, with a 1.9% average annual increase in prevalence over the decade (95% CI, 0.8%-3.0%). Temporal trends in DAMA varied by principal diagnosis. Among patients hospitalized for mental health- or substance abuse-related disorders, there was a -2.3% (95% CI, -3.8% to -0.8%) average annual decrease in the rate of DAMA. A statistically significant temporal rate change was not observed among hospitalizations for pregnancy-related disorders. Multivariable regression revealed several patient and hospital characteristics as predictors of DAMA, including lack of health insurance (odds ratio [OR], 3.78; 95% CI, 3.62-3.94), male sex (OR, 2.40; 95% CI, 2.36-2.45), and northeast region (OR, 1.91; 95% CI, 1.72-2.11). Other predictors included age, race/ethnicity, income, primary diagnosis, severity of illness, and hospital location/type and size. CONCLUSION: Rates for DAMA have increased in the United States, and key differences exist across patient and hospital characteristics. Early identification of vulnerable patients and preventive measures such as improved patient-provider communication may reduce DAMA.


Subject(s)
Patient Discharge/trends , Treatment Refusal , Adult , Aged , Counseling/statistics & numerical data , Cross-Sectional Studies , Diagnosis-Related Groups , Female , Hospitalization/statistics & numerical data , Hospitals/classification , Hospitals/standards , Humans , Inpatients/psychology , Inpatients/statistics & numerical data , Male , Middle Aged , Patient Compliance , Prevalence , Retrospective Studies , Treatment Refusal/psychology , Treatment Refusal/trends , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...